XTNT
Price:
$0.6401
Market Cap:
$89.18M
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor, which contains various proteins and peptides that support ...[Read more]
Industry
Medical - Devices
IPO Date
2010-07-01
Stock Exchange
AMEX
Ticker
XTNT
According to Xtant Medical Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is -27.01%. This represents a change of 303.17% compared to the average of -6.70% of the last 4 quarters.
The mean historical ROE of Xtant Medical Holdings, Inc. over the last ten years is 39.00%. The current -27.01% ROE has changed -169.27% with respect to the historical average. Over the past ten years (40 quarters), XTNT's ROE was at its highest in in the June 2016 quarter at 899.10%. The ROE was at its lowest in in the March 2016 quarter at -166.49%.
Average
39.00%
Median
-8.82%
Minimum
-48.39%
Maximum
275.59%
Discovering the peaks and valleys of Xtant Medical Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 79.36%
Maximum Annual ROE = 275.59%
Minimum Annual Increase = -3078.74%
Minimum Annual ROE = -48.39%
Year | ROE | Change |
---|---|---|
2024 | -38.29% | -3078.74% |
2023 | 1.29% | -105.18% |
2022 | -24.83% | 31.22% |
2021 | -18.92% | -60.89% |
2020 | -48.39% | -360.19% |
2019 | 18.60% | -88.39% |
2018 | 160.15% | 79.36% |
2017 | 89.29% | -67.60% |
2016 | 275.59% | -1225.04% |
2015 | -24.50% | -118.13% |
The current ROE of Xtant Medical Holdings, Inc. (XTNT) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-20.61%
5-year avg
-25.83%
10-year avg
39.00%
Xtant Medical Holdings, Inc.’s ROE is greater than NeuroPace, Inc. (-140.15%), less than Electromed, Inc. (16.50%), greater than Nexalin Technology, Inc. (-277.96%), greater than Surmodics, Inc. (-17.31%), greater than Tenax Therapeutics, Inc. (-31.51%), greater than Oxbridge Re Holdings Limited (-31.83%), greater than Alterity Therapeutics Limited (-183.37%),
Company | ROE | Market cap |
---|---|---|
-140.15% | $297.15M | |
16.50% | $154.56M | |
-277.96% | $20.20M | |
-17.31% | $438.99M | |
-31.51% | $24.73M | |
-31.83% | $17.49M | |
-183.37% | $68.47M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xtant Medical Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Xtant Medical Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Xtant Medical Holdings, Inc.'s ROE?
How is the ROE calculated for Xtant Medical Holdings, Inc. (XTNT)?
What is the highest ROE for Xtant Medical Holdings, Inc. (XTNT)?
What is the 3-year average ROE for Xtant Medical Holdings, Inc. (XTNT)?
What is the 5-year average ROE for Xtant Medical Holdings, Inc. (XTNT)?
How does the current ROE for Xtant Medical Holdings, Inc. (XTNT) compare to its historical average?